Tri- and Tetraalkoxysilanes with Four Different Substituents
J . Org. Chem., Vol. 62, No. 13, 1997 4463
11 (70%) as an oil, which was sufficiently pure for further use.
1H NMR (CDCl3): δ 3.75 (dt, 3H), 2.2 (dp, 3H), 2.1 (bd, 3H),
1.6 (m, 6H), 1.4 (m, 3H), 1.1-0.8 (m, 12H), 0.9 (2d, 18H), 0.8
(d, 9H). 13C NMR (CDCl3): δ 74.5, 49.5, 44.3, 34.4, 31.6, 25.3,
22.7, 22.1, 21.2, 15.7. MS (EI) m/z 528 (M+), 530 (M + 2).
((2-Meth oxyben zyl)oxy)tr is(((1R,2S,5R)-2-isop r op yl-5-
m eth ylcycloh exyl)oxy)sila n e (10). To 0.10 mL of SiCl4
(0.87 mmol) and 0.41 g of (-)-menthol (2.62 mmol) in 25 mL
of toluene was added 0.25 mL of pyridine, and the mixture
was stirred for 1 h at 50 °C. Then 0.120 g of 2-methoxybenzyl
alcohol (0.87 mmol) was added, and the reaction was left
overnight, while cooling to rt. Filtration and evaporation
followed by column chromatography in CH2Cl2/petroleum ether
(1:4) gave 354 mg (64%) of 10. 25 mg of bis((2-methoxybenzyl)-
oxy)bis(((1R,2S,5R)-2-isopropyl-5-methylcyclohexyl)oxy)-
silane was obtained as the second fraction. 10. 1H NMR
(CDCl3): δ 7.5 (d, 1H), 7.2 (t, 1H), 7.0 (t, 1H), 6.8 (d, 1H), 4.9
(s, 2H), 3.8 (s, 3H), 3.7 (dt, 3H), 2.3 (dp, 3H), 2.1 (bd, 3H), 1.6
(m, 6H), 1.4 (m, 3H), 1.2-0.8 (m, 12H), 0.9 (2d, 18H), 0.8 (d,
9H). MS (EI) m/z 630 (M+).
Alternatively 0.276 g of (2 mmol) 2-methoxybenzyl alcohol
and 2.2 g of 11 (4.15 mmol) in 40 mL of toluene was added to
0.4 mL of pyridine, and the mixture was stirred for 3 h.
Filtration and evaporation followed by column chromatography
in CH2Cl2/petroleum ether (1:4) gave 1.21 g (96%) of 10.
(((8-P h en yl-7,9-d ioxo-1,6,8-t r ia za [4.3.0]b icyclon on -3-
en -2-yl)m eth yl)oxy)tr is(((1R,2S,5R)-2-isop r op yl-5-m eth -
ylcycloh exyl)oxy)sila n e (13). To a solution of 0.260 g of 127
(1.0 mmol) and 1.0 g of 11 (1.89 mmol) in 20 mL of toluene
was added 0.2 mL of pyridine, and the solution was stirred
overnight. The solution was filtered through silica with
toluene, evaporated, and column chromatographed in Et2O/
petroleum ether (1:2) giving 0.630 g of 13 (84%). 1H NMR
(CDCl3): δ 7.5-7.2 (m, 5H), 5.95 (d, 2H), 4.55 (bs, 1H), 4.2 (d,
1H), 4.0 (m, 3H), 3.8 (m, 3H), 2.1 (m, 3H), 1.9 (bd, 3H), 1.5
(dt, 6H), 1.2-0.8 (m, 15H), 0.8 (2d, 18H), 0.7 (d, 9H). 13C NMR
(CDCl3): δ 152, 150, 131, 128.8, 127.7, 125.1, 123.8, 120, 73.4,
73.3 (3C), 62.1, 54.7, 49.6, 49.5 (3C), 44.7 (3C), 43.3, 34.4 (3C),
31.6, 31.5 (3C), 25.2 (3C), 22.6 (3C), 22.2 (3C), 21.1 (3C), 15.5
(3C). MS (PDMS) m/z 751 (M+).
((E,E)-Hexa -2,4-d ien yloxy)tr is(((1R,2S,5R)-2-isop r op yl-
5-m eth ylcycloh exyl)oxy)sila n e (14). To 1.5 g of 11 (2.83
mmol) and 0.20 mL of sorbyl alcohol (1.77 mmol) in 20 mL of
toluene was added 3 mL of pyridine, and the mixture was left
stirring overnight. The solution was filtered through silica
with toluene, and the filtrate was evaporated. The residue
was purified using column chromatography in petroleum ether.
First eluted was the starting material when eluting with
petroleum ether, whereafter 14 was eluted with 1% Et2O in
petroleum ether. Yield of 14: 0.890 g (85%). 1H NMR
(CDCl3): δ 6.3-6.0 (m, 2H), 5.75-5.55 (m, 2H), 4.35 (d, 2H),
3.7 (dt, 3H), 2.3 (dp, 3H), 2.1 (bd, 3H), 1.8 (d, 3H), 1.6 (m, 6H),
1.4-1.0 (m, 15H), 0.9 (2d, 18H), 0.8 (d, 9H). 13C NMR
(CDCl3): δ 131.2, 130.3, 129.3, 128.6, 73.3 (3C), 63.5, 49.8 (3C),
44.8 (3C), 34.5 (3C), 31.7 (3C), 25.2 (3C), 22.7 (3C), 22.2 (3C),
21.2 (3C), 18.1, 15.6 (3C).
((((2,5-cis)-5-Meth yl-8-ph en yl-7,9-dioxo-1,6,8-tr iaza[4.3.0]-
b icyclon on -3-en -2-yl)m et h yl)oxy)t r is(((1R,2S,5R)-2-iso-
p r op yl-5-m eth ylcycloh exyl)oxy)sila n e (15). A solution of
30 mg of N-phenylurazole (0.17 mmol) and 18 mg of t-BuOCl
(0.17 mmol) in 2 mL of EtOAc was degassed by being purged
with N2 for 15 min. Then 100 mg of 14 (0.17 mmol) dissolved
in 5 mL of EtOAc was added to the red solution, and the red
color disappeared. The solution was evaporated, and the
residue was column chromatographed in Et2O/petroleum ether
(1:4) giving 121 mg (93%) of 15. 1H NMR (CDCl3): δ 7.4 (m,
5H), 6.0 (d, 1H), 5.9 (dd, 1H), 4.5 (bs, 2H), 4.35 (2dd, 1H), 4.05
(2dd, 1H), 3.7 (dt, 3H), 2.2 (dp, 3H), 2.0 (bd, 3H), 1.6 (d, 6H),
1.5 (d, 3H), 1.4-1.0 (m, 15H), 0.9 (2d, 18H), 0.8 (d, 9H). 13C
NMR (CDCl3): δ 151.6, 128.9, 127.8, 127.6, 127.5, 125.3, 123.0,
73.4, 73.3 (3C), 63.2, 55.5, 55.4, 50.2, 50.1, 49.6 (3C), 44.7, 44.6
(3C), 34.4 (3C), 31.6 (3C), 25.2 (3C), 22.6 (3C), 22.2 (3C), 21.2
(3C), 19.1, 15.6 (3C). MS (PDMS) m/z 765 (M+).
of CH2Cl2 was added 17 mg of maleic anhydride (0.17 mmol),
and the solution was left stirring in the dark for 7 d. The
solvent was evaporated, and the residue was column chro-
matographed in Et2O/petroleum ether (1:4) giving 98 mg (84%)
of 16. 1H NMR (CDCl3): δ 5.95 (m, 1H), 5.8 (dt, 1H), 4.25
(dd, 1H, J 6′a6′b ) 10.4, J 66′a ) 7.1 Hz), 4.15 (2dd, 1H), 3.7 (dt,
3H), 3.5 (dd, 1H, J 1,5 ) 9.3, J 5,6 ) 6 Hz), 3.3 (dd, 1H, J 1,9 ) 7.4
Hz) 2.5 (m, 2H), 2.3 (p, 3H), 2.0 (bd, 3H), 1.6 (d, 6H), 1.4 (d,
3H), 1.4-1.0 (m, 15H), 0.9 (2d, 18H), 0.8 (d, 9H). 13C NMR
(CDCl3): δ 134.4, 134.3, 130.9, 73.4 (3C), 62.5, 49.6 (3C), 45.9,
44.7 (3C), 43.0, 42.9, 38.5, 38.4, 34.4 (3C), 31.6 (3C), 30.7, 30.6,
25.2 (3C), 22.6 (3C), 22.2 (3C), 21.2 (3C), 16.4, 15.6 (3C). MS
(EI) m/z 688 (M+).
((E,E)-Hexa-2,4-dien yloxy)tr is((1,2:4,5-diisopr opyliden e-
fr u ctop yr a n os-3-yl)oxy)sila n e (17). To 1.36 g of 1,2:4,5-
diisopropylidenefructopyranose (2, 5.23 mmol) and 0.2 mL of
SiCl4 (8, 1.74 mmol) was added 0.8 mL of pyridine, and the
mixture was stirred for 3 h at 50 °C. Then 0.27 mL of sorbyl
alcohol (2.38 mmol) was added. The solution was filtered and
evaporated. Column chromatography in Et2O/petroleum ether
(1:3) gave first bis((E,E)-hexa-2,4-dienyloxy)bis(1,2:4,5-diiso-
propylidenefructopyranos-3-oxy)silane (230 mg, 18%) and
second 1.00 g (64%) of 17. 1H NMR (CDCl3): δ 6.1 (m, 2H),
5.6 (m, 2H), 4.4 (d, 2H), 4.2-3.9 (m, 21H), 1.7 (d, 3H), 1.5 (s,
9H), 1.45 (s, 9H), 1.35 (s, 9H), 1.3 (s, 9H). 13C NMR (CDCl3):
δ 131.0, 130.9, 129.2, 128.9, 111.4 (3C), 108.9 (3C), 104.5 (3C),
76.6 (3C), 73.6 (3C), 72.0 (3C), 71.9 (3C), 64.4, 60.8 (3C), 27.9
(3C), 26.3 (6C), 26.0 (3C), 18.0. MS (EI) m/z 902 (M+).
((((2,5-cis)-5-Meth yl-8-ph en yl-7,9-dioxo-1,6,8-tr iaza[4.3.0]-
b icyclon on -3-en -2-yl)m et h yl)oxy)t r is((1,2:4,5-d iisop r o-
p ylid en efr u ct op yr a n os-3-yl)oxy)sila n e (18). N-phenyl-
urazol (30 mg) and 25 mg of tert-butyl hypochlorite in 10 mL
of EtOAc was degassed by being purged with N2 for 15 min.
Then 150 mg of 17 dissolved in EtOAc was added to the red
solution causing the red color to disappear. The solution was
evaporated, and the residue was column chromatographed in
Et2O/petroleum ether (3:1) giving 175 mg (97%) of 18. 1H
NMR (CDCl3): δ 7.4 (m, 5H), 6.1 (m, 1H), 5.8 (m, 1H), 4.6 (m,
2H), 4.5 (m, 2H), 4.3-3.9 (m, 7H), 1.55 (d, 9H), 1.5 (d, 3H),
1.4 (s, 3H), 1.35 (s, 9H), 1.25 (s, 9H). 13C NMR (CDCl3): major
isomer, δ 152.0, 151.5, 131.2, 128.9, 127.8, 127.6, 125.3, 123.0,
111.3 (3C), 108.9 (3C), 104.4 (3C), 76.4 (3C), 73.6 (3C), 72.3
(3C), 72.1 (3C), 63.9, 60.8 (3C), 55.2, 50.6, 27.9 (3C), 26.4 (3C),
26.1 (3C), 26.0 (3C), 19.1; minor isomer, δ 152.4, 151.1, 131.2,
128.9, 127.8, 127.6, 125.5, 122.8, 111.4 (3C), 108.8 (3C), 104.5
(3C), 76.4 (3C), 73.7(3C), 72.4(3C), 72.0 (3C), 64.0, 60.7 (3C),
54.8, 51.0, 28.0 (3C), 26.4 (3C), 26.1 (3C), 26.0 (3C), 19.4. MS
(EI) m/z 1077 (M+).
(((5-Met h yl-7,9-d ioxo-8-oxa [4.3.0]b icyclon on -3-en e-2-
yl)m eth yl)oxy)tr is(1,2:4,5-diisopr opyliden efr u ctopyr an os-
3-yl)oxy)sila n e (19). To 150 mg of 17 (0.17 mmol) in 2 mL
of EtOAc was added 16 mg of maleic anhydride (0.16 mmol),
and the mixture was left to stir in the dark for 7 d. The solvent
was evaporated, and the residue was subjected to column
chromatography (Et2O/petroleum ether (1:1)) to give 100 mg
(60%) of 19. 13C NMR (CDCl3): δ 171.4, 134.3, 134.2, 131.3,
131.0, 111.53, 111.48 (3C), 108.90, 108.87 (3C), 104.60, 104.56
(3C), 76.7 (3C), 73.6 (3C), 72.4 (3C), 72.1, 72.0 (3C), 63.6, 63.4,
60.84, 60.78 (3C), 46.0, 45.9, 43.0, 42.8, 38.2, 38.1, 30.6, 30.5,
28.0 (3C), 26.4 (3C), 26.1 (3C), 26.0 (3C), 16.4. MS (EI) m/z
1024 (M + Na).
Bis(ben zyloxy)bis((1-O-m eth yl-2,4,6-tr i-O-ben zyl-r-D-
glu cop yr a n os-3-yl)oxy)sila n e (20). To a solution of 125 mg
of methyl 2,4,6-tri-O-benzyl-R-D-glucopyranoside in 10 mL of
toluene was added first 0.17 mL of a 9.1% SiCl4 (v/v) in toluene
solution and then 0.2 mL of pyridine. After the solution was
stirred for 1 h, 0.03 mL of BnOH was added to the reaction
mixture, and the mixture was left to stir overnight. The
mixture was filtered and concentrated. Column chromatog-
raphy in Et2O/petroleum ether (1:1) gave 95 mg (60%) of 20.
1H NMR (CDCl3): δ 7.2-7.4 (m, 40H), 5.1 (d, 2H), 4.9 (d, 4H),
4.4-4.8 (m, 14H), 3.4-3.8 (m, 10H), 3.3 (s, 6H). 13C NMR
(CDCl3): δ 140.4, 138.7, 137.8, 128.3, 128.2, 128.0, 127.8, 127.6,
127.5, 127.4, 127.1, 126.5, 126.3, 98.0, 80.0, 78.4, 75.4, 74.2,
73.4, 73.1, 69.6, 68.6, 65.1, 54.9.
(((5-Meth yl-7,9-d ioxo-8-oxa [4.3.0]bicyclon on -3-en -2-yl)-
m eth yl)oxy)tr is(((1R,2S,5R)-2-isop r op yl-5-m eth ylcyclo-
h exyl)oxy)sila n e (16). To 100 mg of 14 (0.17 mmol) in 2 mL